Endothelial dysfunction may also result from hyperglycemia and atherosclerosis, and some studies have suggested that sitagliptin can improve endothelial dysfunction in patients with type 2 diabetes and that gliptins may protect endothelial function through a GLP-1-dependent mechanism [21, 22]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.